Full Project 4: Molecular Pathways to Breast Cancer Mortality among African American and White Women
Full Project 4: Molecular Pathways to Breast Cancer Mortality among African American and White Women
批准号:
10004337
负责人:
Jodie Michelle Fleming
金额:
$20.06万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2023-08-31
关键词:
AddressAffectAfrican AmericanAgeBioinformaticsBiologicalBiological AssayBiologyBiometryBreast Cancer Risk FactorCategoriesCaucasiansClinicalClinical DataCohort StudiesCountyCritical PathwaysDataData SetDiseaseEpidemiologyEpidermal Growth Factor ReceptorEstrogen receptor negativeEstrogen receptor positiveEstrogensExposure toFacultyFaculty RecruitmentGene ExpressionGenesGenetic TranscriptionGrowth Factor GeneHGF geneHealth SciencesHealth ServicesHypoxiaImmuneImmune responseIncidenceInsulinInsulin-Like Growth Factor IKnowledgeLeadLife StyleLinkMalignant NeoplasmsMammary NeoplasmsMethodologyMethodsMinorityMissionModalityMolecularMolecular GeneticsNatural ImmunityNucleic AcidsOutcomeParticipantPathway interactionsPatientsPopulation ResearchPublic HealthPublic Health SchoolsRNARaceResearchResearch MethodologyRisk FactorsSamplingSignal TransductionSpecialized Program of Research ExcellenceStudentsSurvival AnalysisTP53 geneTamoxifenTechnologyTissuesTranslational ResearchTranslationsTreatment outcomeWomanWorkadaptive immunityanticancer researchbasebiological heterogeneitycancer health disparityexperiencegenetic signaturehealth disparitymalignant breast neoplasmmedical schoolsmolecular subtypesmortalitymortality disparitynano-stringnovelphase 3 studypopulation basedresponsesurvival predictionsurvivorshiptumortumor heterogeneitywound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Relative to white women, African American women have higher incidence of breast cancer before age
40 and suffer higher mortality at all ages. The Carolina Breast Cancer Study has shown that African American
women are more likely to get estrogen receptor negative breast cancer and triple negative or basal-like breast
cancers. Furthermore, when African American women get estrogen receptor positive breast cancers, their
survivorship is lower than white women with similar disease. To better understand the biological pathways that
lead to incidence mortality disparities, we will collect RNA expression data from Carolina Breast Cancer Study
tumors. The Carolina Breast Cancer Study Phase 3 is a cohort study of 3000 women with breast cancer, half
of which are African American women. The study was conducted in 44 counties and used population-based
sampling, therefore representing catchment for the state. Detailed treatment and clinical data are available for
survivorship analyses. Aim 1 will use RNA expression levels to classify participants according to tumor gene
expression in crucial biologic pathways: estrogen responsiveness among luminal breast cancers, hepatocyte
growth factor (HGF)-signaling among basal-like breast cancers, and immune response pathways in all
subtypes. Aim 2 will link heterogeneity in tumor gene expression with exposure to breast cancer risk factors.
Finally Aim 3 will link tumor gene expression with cancer outcomes. Novel data collected in this application will
be combined with existing data on other important breast cancer pathways (e.g. intrinsic subtype, p53
expression subtype, EGFR signaling, hypoxia signaling, etc.) to develop a complete picture of the biology of
breast cancer disparities. This project will also support an NCCU-UNC partnership by extending successful
methods developed in the UNC Breast Cancer Specialized Program of Research Excellence, and transfering
this knowledge to support our Lineberger-NCCU partnership. UNC Lineberger has a state-wide mission, a top
ranked school of public health, and an outstanding medical school. Partnership-recruited faculty and trainees
will gain expertise in research methods and technology not typically available on a campus without these
health sciences strengths. Thus, while the research addresses a health disparity, the implementation of the
project will also address a gap faced in conducting high impact public health and clinical/translational work at
NCCU. This project will have both an important disparities and partnership endpoints.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
-
批准号:10204739
-
项目类别:
-
资助金额:$26.83万
-
财政年份:2017
-
负责人:Jodie Michelle Fleming
-
依托单位:
Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
-
批准号:9977714
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2017
-
负责人:Jodie Michelle Fleming
-
依托单位:
HGF signaling in African-American and Basal-like Breast Cancer
-
批准号:8726349
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2013
-
负责人:Jodie Michelle Fleming
-
依托单位:
HGF signaling in African-American and Basal-like Breast Cancer
-
批准号:8491064
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2013
-
负责人:Jodie Michelle Fleming
-
依托单位:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
-
批准号:8337127
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2012
-
负责人:Jodie Michelle Fleming
-
依托单位:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
-
批准号:8731643
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2012
-
负责人:Jodie Michelle Fleming
-
依托单位:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
-
批准号:8551659
-
项目类别:
-
资助金额:$9.78万
-
财政年份:2012
-
负责人:Jodie Michelle Fleming
-
依托单位:
Full Project 1: LSR Alters Metabolic Signaling to Drive Aggressive Breast Cancer Behaviors
-
批准号:9050348
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2010
-
负责人:Jodie Michelle Fleming
-
依托单位:
Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
-
批准号:9750532
-
项目类别:
-
资助金额:$29.86万
-
财政年份:--
-
负责人:Jodie Michelle Fleming
-
依托单位:
Full Project 1: LSR Alters Metabolic Signaling to Drive Aggressive Breast Cancer Behaviors
-
批准号:9152333
-
项目类别:
-
资助金额:$18.9万
-
财政年份:--
-
负责人:Jodie Michelle Fleming
-
依托单位:
海外基金